Author(s):
Andraz, S. ; Pereira, J. Massa ; Costa, H. ; Espirito Santo, M. ; Hamann, L. ; Fernandes, R. ; Bispo, J. ; Carvalho, D. ; Bento, D. ; Azevedo, P. ; Mimoso, J.
Date: 2024
Persistent ID: http://hdl.handle.net/10400.1/26337
Origin: Sapientia - Universidade do Algarve
Description
Atherosclerotic cardiovascular disease (ASCVD) is a global health challenge, prompting widespread use of conventional risk assessment tools (SCORE2 in Europe and the ASCVD Risk calculator in the United States) to guide preventive strategies. Emerging evidence indicates that high-sensitivity cardiac troponin (hsTn) may refine risk stratification.